IRAK degraders and uses thereof
US11542251B2 · kind B2 · utility
1Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2019 |
| Grant date | Jan 3, 2023 |
| Priority date | — |
| Expiry date | Feb 13, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to heterobifunctional compounds (degraders), compositions and methods for treating diseases or conditions mediated by Interleukin Receptor-Associated Kinases (IRAKs).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.